Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

NCT00922506 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder
Benign Prostatic Hyperplasia

Interventions

DRUG: doxazosin plus tolterodine SR

Sponsor

Samsung Medical Center